Home ~ About us ~ Ahead of print ~ Current Issue ~ Back Issues ~ Search ~ Instructions ~ Subscription ~ Advertise ~ Feedback ~ Login  
  Mens Sana Monographs
A Monograph Series Devoted To The Understanding Of Medicine, Mental Health, Man, Mind, Music And Their Matrix
 Why MSM | Acknowledgement | Call for papers... | Forthcoming MSM...  Users online: 480  Home Email this article Print this Article Bookmark this page Decrease font size Default font size Increase font size 
This article has been cited by
1Possible natural therapeutics against schizophrenia and its acute and treatment resistant forms: a review
Abhijit Dey,Saheli Das,Anuradha Mukherjee
Journal of Biologically Active Products from Nature.2016;6(1)1
[DOI]
2Perfil clínico e sociodemográfico de pacientes com esquizofrenia refratária tratados em um centro terciário
Marceli Cezaretto,Ester Franco de Souza Freitas Silva,Ariane Ambrizzi,Victor Eduardo Dutra de Biase,Elissandro de Freitas Silva,Emirene Maria Trevisan Navarro da Cruz,Fabio Aparecido Borghi,Gerardo Maria de Araújo Filho
Jornal Brasileiro de Psiquiatria.2014;63(3)185
[DOI]
3Clozapine underutilization in treatment-resistant schizophrenia
Robert J. Stanton,Chris Paxos,Werner J. Geldenhuys,B Pharm,Jessica L. Boss,Mark Munetz,Altaf S. Darvesh,M Pharm
Mental Health Clinician.2015;5(2)63
[DOI]
4Clotiapine in schizophrenia: a guide to its use
Katherine A. Lyseng-Williamson
Drugs & Therapy Perspectives.2015;31(11)365
[DOI]
5Clozapine and Psychosocial Function in Schizophrenia: A Systematic Review and Meta-Analysis
Andrew T. Olagunju,Scott R. Clark,Bernhard T. Baune
CNS Drugs.2018;32(11)1011
[DOI]
6Basal Exposure Therapy: A New Approach for Treatment-Resistant Patients with Severe and Composite Mental Disorders
Didrik Heggdal,Roar Fosse,Jan Hammer
Frontiers in Psychiatry.2016;7(11)1011
[DOI]
7Electroconvulsive Therapy Added to Non-Clozapine Antipsychotic Medication for Treatment Resistant Schizophrenia: Meta-Analysis of Randomized Controlled Trials
Wei Zheng,Xiao-Lan Cao,Gabor S. Ungvari,Ying-Qiang Xiang,Tong Guo,Zheng-Rong Liu,Yuan-Yuan Wang,Brent P. Forester,Stephen J. Seiner,Yu-Tao Xiang,Peter John McKenna
PLOS ONE.2016;11(6)e0156510
[DOI]
8Clozapine: a guide to its use in patients with schizophrenia who are unresponsive to or intolerant of other antipsychotic agents
Katherine A. Lyseng-Williamson
Drugs & Therapy Perspectives.2013;29(6)161
[DOI]
9Mirtazapine adjunct for people with schizophrenia
Luke A Perry,Dhruvesh Ramson,Suzanne Stricklin
Cochrane Database of Systematic Reviews.2018;29(6)161
[DOI]
10Electroconvulsive therapy in treatment of resistant schizophrenia: biological markers of efficacy and safety
M. V. Ivanov,D. S. Zubov
Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova.2019;119(3)92
[DOI]
11Treating the violent patient with psychosis or impulsivity utilizing antipsychotic polypharmacy and high-dose monotherapy
Debbi A. Morrissette,Stephen M. Stahl
CNS Spectrums.2014;19(5)439
[DOI]
12A pilot randomized controlled trial of the Occupational Goal Intervention method for the improvement of executive functioning in patients with treatment-resistant schizophrenia
Adriana D.B. Vizzotto,Diego L. Celestino,Patricia C. Buchain,Alexandra M. Oliveira,Graça M.R. Oliveira,Elaine S. Di Sarno,Isabel C. Napolitano,Helio Elkis
Psychiatry Research.2016;245(5)148
[DOI]
13Study of negatives symptoms in first episode schizophrenia
Vivek Bambole,Nilesh Shah,Shushma Sonavane,Megan Johnston,Amresh Shrivastava
Open Journal of Psychiatry.2013;03(03)323
[DOI]
14Evaluation of a few discrete clinical markers may predict categorization of actively symptomatic non-acute schizophrenia patients as treatment resistant or responders: A study by ROC curve analysis and multivariate analyses
Felice Iasevoli,Camilla Avagliano,Benedetta Altavilla,Annarita Barone,Mariateresa Ciccarelli,Luigi D'Ambrosio,Danilo Notar Francesco,Eugenio Razzino,Michele Fornaro,Andrea de Bartolomeis
Psychiatry Research.2018;269(03)481
[DOI]
15Clozapine oral suspension (Versacloz™): a guide to its use in the USA
Katherine A. Lyseng-Williamson
Drugs & Therapy Perspectives.2014;30(6)193
[DOI]
16The emerging role of dopamine–glutamate interaction and of the postsynaptic density in bipolar disorder pathophysiology: Implications for treatment
Andrea de Bartolomeis,Elisabetta F Buonaguro,Felice Iasevoli,Carmine Tomasetti
Journal of Psychopharmacology.2014;28(6)505
[DOI]
17Intracellular pathways of antipsychotic combined therapies: Implication for psychiatric disorders treatment
Andrea de Bartolomeis,Livia Avvisati,Felice Iasevoli,Carmine Tomasetti
European Journal of Pharmacology.2013;718(1-3)502
[DOI]
18Combined use of electroconvulsive therapy and antipsychotics (both clozapine and non-clozapine) in treatment resistant schizophrenia: A comparative meta-analysis
Saeed Ahmed,Ali Mahmood Khan,Hema Madhuri Mekala,Hema Venigalla,Rizwan Ahmed,Amira Etman,Michael Esang,Mustafa Qureshi
Heliyon.2017;3(11)e00429
[DOI]
19Making clozapine safer: current perspectives on improving its tolerability
Bosky Nair,James Hunter MacCabe
Future Neurology.2014;9(3)313
[DOI]
20An ethanolic extract of Desmodium adscendens exhibits antipsychotic-like activity in mice
Patrick Amoateng,Samuel Adjei,Dorcas Osei-Safo,Kennedy K.E. Kukuia,Thomas K. Karikari,Alexander K. Nyarko
Journal of Basic and Clinical Physiology and Pharmacology.2017;28(5)313
[DOI]
21Mirtazapine (adjunct) versus placebo for schizophrenia
Suzanne Stricklin,Luke A Perry,Dhruvesh Ramson
Cochrane Database of Systematic Reviews.2015;28(5)313
[DOI]
22Treatment resistant schizophrenia: Clinical, biological, and therapeutic perspectives
Frederick C. Nucifora,Edgar Woznica,Brian J. Lee,Nicola Cascella,Akira Sawa
Neurobiology of Disease.2018;28(5)313
[DOI]
23The effect of transcranial direct current stimulation on psychotic symptoms of schizophrenia is associated with oxy-hemoglobin concentrations in the brain as measured by near-infrared spectroscopy: A pilot study
Zui Narita,Takamasa Noda,Shiori Setoyama,Kazuki Sueyoshi,Takuma Inagawa,Tomiki Sumiyoshi
Journal of Psychiatric Research.2018;103(5)5
[DOI]
24Dopamine serotonin stabilizer RP5063: A randomized, double-blind, placebo-controlled multicenter trial of safety and efficacy in exacerbation of schizophrenia or schizoaffective disorder
Marc Cantillon,Arul Prakash,Ajay Alexander,Robert Ings,Dennis Sweitzer,Laxminarayan Bhat
Schizophrenia Research.2017;189(5)126
[DOI]
25Stimulants for impulsive violence in schizophrenia spectrum disordered women: a case series and brief review
Philip Skoretz,Chin Tang
CNS Spectrums.2016;21(6)445
[DOI]
  Why MSM 
  Acknowledgement 
  Call for papers... 
  Forthcoming MSM... 
  My Preferences